ArticleScientific reports2025
Bioinspired Conyza bonariensis-mediated ZnO/rGO NCs for effective degradation of toxic compounds under visible-light irradiation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A green and sustainable approach usingRSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study reports a green, cost-effective synthesis of ZnO/rGO nanocomposites (NCs) using Conyza bonariensis leaf extract as a novel bio-reducing agent. The nanocomposites were prepared via a simple hydrothermal method. Extensive characterization techniques including XRD, FT-IR, EDS, UV-DRS, XPS, BET, SEM, TEM, and AFM were employed to evaluate the crystallite size, phase structure, chemical composition, surface morphology, porosity, and particle size of the synthesized material. XRD analysis confirmed the formation of a hexagonal wurtzite ZnO phase with an average crystallite size of approximately 17.22 nm, calculated using the Debye-Scherrer equation. SEM revealed a distinctive "tuberose flower"-like morphology of ZnO particles distributed on the reduced graphene oxide (rGO) sheets, with flower diameters ranging from 1 to 2 μm and petal widths of 40-70 nm. Further, TEM supported the uniform distribution of ZnO tubular petals on graphene nanosheets. BET analysis demonstrated the mesoporous nature of NCs. Remarkably, the bioinspired ZnO/rGO NCs exhibited excellent photocatalytic activity under visible-light irradiation, effectively degrading industrial dyes such as Congo red (CR), Methylene blue (MB), and Thymol blue (TB). The enhanced photocatalytic performance is attributed to the nanocomposites' unique scaffold-like architecture, increased light absorption, and efficient charge separation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.